NEW YORK (GenomeWeb News) – Source BioScience reported today an 11 percent increase year over year in revenues for the first half of 2012.

For the six months ended June 30, total revenues came in at £8.4 million (US$13.3 million), up from £7.6 million a year ago, paced by a 22 percent jump in revenues within the Healthcare segment to £4.4 million from £3.6 million a year ago. Revenues in the firm's Life Sciences segment were flat at £4.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.